Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment

Figure 8 Radiotherapy treatment planning of a 70-yr-old male patient with two hypovascular hepatocellular carcinomas in segment VIII (4. 3 cm) and segment VI (1.3 cm). A-C: Hepatobiliary phase magnetic resonance imaging (MRI); D-F: Computed tomography (CT) simulation for radiation therapy planning. In the upper panel from A to C are reported hepatobiliary phase MRI images prior to stereotactic ablative radiotherapy treatment. In the bottom panel from D to F are reported CT images from radiotherapy treatment plan with isodose curve distributions.